Country Profile

Portugal

Portugal is an emerging destination for Indian pharmaceutical exports — $42.2M in FY 2025–26, with 3.0× growth over the past decade. Medicine Ingredients accounts for 54% of shipments. The compound annual growth rate since FY2015 stands at 10.5%.

🇵🇹 $42.2M · 3.0× growth since FY2015 · 10.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$42.2M
Exports FY2025–26 DGCIS
3.0×
Growth FY2015→2026
10.5%
CAGR FY2015→2026
54%
Medicine Ingredients Share
4
Product Categories Supplied
Portugal is an emerging destination for Indian pharmaceutical exports — $42.2M in FY 2025–26, with 3.0× growth over the past decade. Medicine Ingredients accounts for 54% of shipments. The compound annual growth rate since FY2015 stands at 10.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $22.7M (53.8%) Medicines $18.3M (43.4%) Surgical & Hospital Supplies $1.13M (2.7%) Traditional & Herbal $70K (0.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Portugal in the RBI overseas direct investment dataset (2011–2026).